Skip to content

IMPlementation of Evidence Based Facility and Community Interventions to Reduce the Treatment Gap for depRESSion

IMPlementation of Evidence Based Facility and Community Interventions to Reduce the Treatment Gap for depRESSion

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05890222
Acronym
IMPRESS
Enrollment
784
Registered
2023-06-06
Start date
2023-11-01
Completion date
2026-04-30
Last updated
2025-05-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depression

Brief summary

The goal of this Hybrid Type 2 Implementation-Effectiveness Cluster Randomised Controlled Trial is to reduce the treatment gap for depression through the integrated implementation of interventions in facility and community platforms, in Goa, India. The primary question is to examine whether a community intervention (Community Model) enhances the demand for, and improves the outcomes of, an evidence-based, brief psychological treatment for depression delivered by non-specialist health workers in primary health care facilities (Facility Model). Participants in the Facility Model arm will receive only a psychosocial intervention for depression (the Healthy Activity Program - HAP) while participants in the Community Model will receive both the HAP and the community intervention. We will compare the Facility Model and the Community Model to assess if the latter is superior in increasing the demand for depression treatment in primary care, increasing uptake of treatment by people with depression, increasing treatment completion rates, and reducing the severity of depression.

Interventions

Community intervention strategies will be delivered by community volunteers (called Sangathis - which means companion in Konkani, one of the local languages) to i) enhance demand for the HAP treatment and ii) promote engagement with, and completion of, the HAP treatment. The community intervention is co-produced with local community members and includes strategies such as activities to increase awareness about depression (community meetings, street plays and health camps), and dissemination of psycho-educational materials (i.e., leaflets and posters), identify people with possible depression in the community, and facilitate access to HAP in the health centres. Additionally, the Sangathis will coordinate continuing care of people receiving HAP, through home visits to encourage behavioural activation, homework completion and following up with the counsellor, and engaging family members to support the patient in achieving treatment goals.

HAP includes the following strategies: psychoeducation, behavioural assessment, activity monitoring, activity structuring and scheduling, activation of social networks, and problem-solving. HAP will be delivered in an individual format. It entails three phases of treatment, delivered over six to eight sessions, each lasting up to 40 minutes, with the sessions being at weekly intervals. Sessions will be delivered face-to-face, at the health centre where the counsellors already work.

Sponsors

London School of Hygiene and Tropical Medicine
CollaboratorOTHER
Harvard Medical School (HMS and HSDM)
CollaboratorOTHER
Centre for Addiction and Mental Health
CollaboratorOTHER
Sangath
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

(A) Contact Coverage Outcome Inclusion Criteria * Adults (\>18 years) * Residing in the clusters included in the trial * Speak English or one of the local languages (Konkani, Marathi, Hindi)

Exclusion criteria

* Patients with significant speech, hearing, or language impairment that interferes with completion of the screening and/or receipt of psychosocial intervention * Patients who present to the health centre for emergency medical attention * Patients with active psychotic symptoms (B) Effectiveness Coverage Outcome Inclusion Criteria * Adults (\>18 years); * Residing in the clusters included in the trial * Speak English or one of the local languages (Konkani, Marathi, Hindi). * Screen positive for moderately severe or severe depression (total score \>14) on the Patient Health Questionnaire-9 items (PHQ-9)

Design outcomes

Primary

MeasureTime frameDescription
Contact coverageDuring recruitmentPatient Health Questionnaire 9 items (PHQ-9) score \>4. The minimum score is 0 and maximum score is 27; with higher scores indicating greater severity of depression.
Effectiveness coverageThree months post recruitmentMean Patient Health Questionnaire 9 items (PHQ-9 score). The minimum score is 0 and maximum score is 27; with higher scores indicating greater severity of depression.

Secondary

MeasureTime frameDescription
Response to treatmentThree months post recruitment\>50% reduction in Patient Health Questionnaire 9 items (PHQ-9 score) score. The minimum score is 0 and maximum score is 27; with higher scores indicating greater severity of depression.
Client Service Receipt Inventory3- and 6- months post recruitmentOut-of-pocket costs for receiving care and the related non-medical costs
WHO Disability Assessment Schedule (WHODAS 2.0)Baseline, 3- and 6- months post recruitmentStandardized disability scores used to estimate Quality Adjusted Life Years (QALYs). The 12-item WHODAS 2.0 score ranges from 12 to 60, where higher scores indicate higher disability or loss of function.
Survey form for collecting costs of receiving HAP intervention to patients3 months post recruitmentOut-of-pocket costs for receiving HAP intervention (e.g. time loss, travel)
Inventory form for collecting system-level economic costs of delivering interventionsMonthly, through study completion up to approximately 12 monthsSystem-level costs: Economic costs in WHO six building blocks for delivering the interventions
Sustained effectivenessSix months post recruitmentMean Patient Health Questionnaire 9 items (PHQ-9 score). The minimum score is 0 and maximum score is 27; with higher scores indicating greater severity of depression.
Perceived social support3- and 6- months post recruitmentPerception of social support received. This will be a bespoke tool developed for our trial and will have questions to assess perceived support related to support provided by community volunteers in our community intervention and higher scores will indicate greater support.
Multidimensional Scale of Perceived Social Support (MSPSS)Baseline, 3- and 6-months post-recruitment12 item short instrument designed to measure an individual's perception of support from 3 sources: family, friends and a significant other. Minimum score 12 and maximum 84
Treatment completionAcross 12 months of implementationMet treatment goals or completed the maximum number of sessions or were referred to mental health specialists
Behavioral activationBaseline, 3- and 6- months post recruitment.Level of behavioral activation measured using PREMIUM Abbreviated Activation Scale. This is a five-item scale, originally developed based on the Behavioural Activation for Depression Scale. It includes five self-reported indicators and the total score can range from 0 to 20. Higher scores indicate greater level of behavioural activation such as engagement with a variety of activities, and associated pleasure and mastery.
Depression awarenessBaseline, 6, 12 and 18 months of implementationAwareness about depression. This will be a bespoke tool developed for our trial and will have questions to assess awareness related to depression based on the information disseminated in our community intervention and higher scores will indicate greater awareness.
RemissionThree months post recruitmentPatient Health Questionnaire 9 items (PHQ-9 score) score \<10. . The minimum score is 0 and maximum score is 27; with higher scores indicating greater severity of depression.

Countries

India

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 6, 2026